Ledger.Open graph →
SEC Form D · filed March 16, 2021

Interline Therapeutics, Inc

Offering
$32.5M
Sold
$32.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Vikram Bajaj · South San Francisco, CADirectorZachary Sweeney · South San Francisco, CAExec · DirectorMatthew Christensen · Austin, TXDirectorCharman Driver · Raleigh, NCExec · DirectorVikram Bajaj · South San Francisco, CADirectorJames Tananbaum · South San Francisco, CADirectorJim Geikie · Raleigh, NCDirectorAndrew J. Guff · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗